NEW YORK, May 8, 2013 /PRNewswire/ -- Paradigm Spine LLC, a provider of innovative spinal implant technologies, announced today the launch of its new coflex® Solution patient-centric website (www.coflexsolution.com) to help provide patients with information related to the symptoms of Lumbar Spinal Stenosis and both non-surgical and surgical treatment options for the disease. The U.S. Food and Drug Administration granted Premarket Approval ("PMA") for coflex®, a minimally invasive, Motion Preserving Interlaminar Stabilization™ device that is the first and only alternative to fusion for the treatment of Moderate To Severe Stenosis With Or Without Back Pain™ in October, 2012.
"We are pleased to provide potential patients with an easy-to-use resource on how the coflex® device may be an option for treatment of Lumbar Spinal Stenosis. Our new coflex® Solution website provides easy-to-understand information about the disease and various treatment pathways, including a demonstration of how the coflex® device functions. The website also provides potential patients with access to further informational resources through our coflex® Solution hotline and trained surgeon locator," stated Marc Viscogliosi, Chairman & CEO of Paradigm Spine.
About Paradigm Spine LLC
Paradigm Spine LLC, founded by Viscogliosi Bros., LLC in 2004, is a privately held company focused on the design, development and marketing of solutions for the treatment of spinal conditions and diseases. The company's signature product is the coflex® Interlaminar Stabilization™ device, which has more than 18 years of clinical history with regulatory approval in more than 40 countries throughout 6 continents. For more information on Paradigm Spine LLC, please visit the company's website at www.paradigmspine.com.
Marc R. Viscogliosi, Chairman & CEO
(212) 367-7274, Ext. 2103
SOURCE Paradigm Spine LLC